Wu C C, Yen M H
Department of Pharmacology, National Defense Medical Center, Taipei, Republic of China, Taiwan.
Am J Hypertens. 1999 May;12(5):476-82. doi: 10.1016/s0895-7061(99)00008-4.
We had detected a slightly, but significantly, higher level of plasma nitrite/nitrate in the spontaneously hypertensive rat (SHR) by using the nitric oxide (NO) analyzer (Sievers 280 NOA), which converts nitrate (including nitrate converted from nitrite) to NO. Here, we examined whether the release of NO from protein-bound dinitrosyl nonheme iron complexes (DNIC) contributes to the elevated plasma nitrate level in the SHR. The SHR and their genetic normotensive controls, Wistar-Kyoto rats (WKY), were anesthestized and cannulized for monitoring blood pressure, collecting a blood sample, and the administration of endotoxin (lipopolysaccharide [LPS]). The nitrate levels (an indicator of NO formation) in the plasma and the aorta were measured by an NO analyzer. In addition, the relaxation of acetylcholine (ACh) in the presence or absence of N(omega)-nitro-L-arginine methyl ester (L-NAME) was also examined in thoracic aortae obtained from both strains. The slight, but significant, increase of basal nitrate levels in the plasma and aorta were observed, and the former was further enhanced in SHR treated with LPS for 3 h. In vitro, the ACh-induced relaxation was attenuated in the aortae obtained from SHR. However, this difference between SHR and WKY (without LPS treatment) was abolished by treatment of rings with L-NAME (30 micromol/L), suggesting that an impairment of NO formation was observed in the SHR. After rats were treated with LPS for 3 h, the ACh-induced relaxation was reduced in the WKY, but not in the SHR. In addition, a 10-fold increase of L-NAME was needed to abolish the difference in ACh-induced relaxation between SHR and WKY, indicating an expression of inducible NO synthase in both strains treated with LPS. We suggest that the elevated plasma NO level in SHR may be due to the release of NO from DNIC in the vascular bed to combat the hypertensive state.
我们使用一氧化氮(NO)分析仪(Sievers 280 NOA)检测到自发性高血压大鼠(SHR)血浆中亚硝酸盐/硝酸盐水平略有升高,但具有显著差异,该分析仪可将硝酸盐(包括由亚硝酸盐转化而来的硝酸盐)转化为NO。在此,我们研究了蛋白质结合的二亚硝基非血红素铁络合物(DNIC)释放的NO是否导致SHR血浆硝酸盐水平升高。将SHR及其基因正常血压对照Wistar-Kyoto大鼠(WKY)麻醉并插管,用于监测血压、采集血样以及给予内毒素(脂多糖[LPS])。通过NO分析仪测量血浆和主动脉中的硝酸盐水平(NO生成的指标)。此外,还在两种品系的胸主动脉中检测了在存在或不存在N(ω)-硝基-L-精氨酸甲酯(L-NAME)的情况下乙酰胆碱(ACh)引起的舒张情况。观察到血浆和主动脉中基础硝酸盐水平略有但显著升高,在用LPS处理3小时的SHR中前者进一步升高。在体外,从SHR获得的主动脉中ACh诱导的舒张减弱。然而,用L-NAME(30 μmol/L)处理血管环后,SHR和WKY(未用LPS处理)之间的这种差异消失,表明在SHR中观察到NO生成受损。在用LPS处理大鼠3小时后,WKY中ACh诱导的舒张减弱,但SHR中未减弱。此外,需要将L-NAME增加10倍才能消除SHR和WKY之间ACh诱导舒张的差异,表明在用LPS处理的两种品系中均有诱导型NO合酶表达。我们认为,SHR中血浆NO水平升高可能是由于血管床中DNIC释放NO以对抗高血压状态。